Comparison of Pantoprazole and Ranitidine in Dyspepsia

Phase

Condition

Colic

Heartburn

Heartburn (Pediatric)

Treatment

N/A

Clinical Study ID

NCT01737840

160

Ages > 18
All Genders

Study Summary

The H0 hypothesis of the study is there is no difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Epigastric pain
Older than 18 years old

Exclusion

Exclusion Criteria:

Diagnosed as cholecystitis, pancreatitis, myocardial infarction, etc.. at the end ofthe emergency deparment evaluation period.
Pregnancy
Patients with unstable vital signs
Patients used anti-acid, H2 receptor blockers and proton pomp inhibitors in the lastone hour.
Allergy to H2 receptor blockers and proton pomp inhibitors.
Patients denied to give inform consent and who are illiterate

Study Design

October 01, 2012

January 31, 2013

Study Description

Dyspepsia is one of the common complaints in emergency department. Proton pomp inhibitors, H2 receptor blockers and anti-acids are common drugs for treating dyspepsia in emergency department. However there is no study in the emergency department comparing the effectiveness of these drugs. So the investigators planned this study which drug is effective in these patients in order to provide a cost-effective treatment in dyspeptic patients.

Connect with a study center

Akdeniz University
Antalya, 07050
Turkey
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.